Drug Approval | November 19, 2021
Natco launches Tipanat tablets in India
It is used for the treatment of advanced colorectal and gastric cancer
It is used for the treatment of advanced colorectal and gastric cancer
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
Two out of three people under the age of 40 are at risk of prediabetes
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
_256_384.png)
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
The workshop had been organized by the department of surgery at Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), along with the Association of Surgeons of Aligarh (ASA)
Subscribe To Our Newsletter & Stay Updated
